New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Botanix Pharmaceuticals Limited
BOT.AX
Shape
US Flag

ASX

Unprofitable

Unprofitable

599M

Biotechnology

0.33AUD
Shape0.01 ( 3.13%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

23%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

26%

Quote Panel

Shape
Updated October 27, 2024
1W -4.35 % 1M -18.52 % 3M -12.00 % 1Y 135.71 %

Key Metrics

Shape
  • Market Cap

    598.63M


  • Shares Outstanding

    1.82B


  • Share in Float

    1.35B


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    0.33


  • Average Volume

    6.21M


  • Beta

    1.713


  • Range

    0.125-0.445


  • Industry

    Biotechnology


  • Website

    https://www.botanixpharma.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

289.27x

P/S Ratio

4.75x

P/B Ratio

0.0

Debt/Equity

-670.2%

Net Margin

$-0.0

EPS

How BOT.AX compares to sector?

P/E Ratio

Relative Strength

Shape

BOT.AX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$32M

Shape1804%

2025-Revenue

$0.00

Shape35%

2025-EPS

$32M

Shape-283%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.19

arrow
arrow

N/A

-0.01
vs -0.01

Q2.20

arrow
arrow

N/A

-0.01
vs -0.02

Q4.20

arrow
arrow

+109%

0
vs -0.01

Q2.21

arrow
arrow

N/A

-0.00
vs -0.01

Q4.21

arrow
arrow

N/A

-0.01
vs 0

Q2.22

arrow
arrow

N/A

-0.01
vs -0.00

Q4.22

arrow
arrow

N/A

-0.00
vs -0.01

Q2.23

arrow
arrow

N/A

-0.00
vs -0.01

Q4.23

arrow
arrow

N/A

-0.00
vs -0.00

Q2.24

arrow
arrow

N/A

-0.01
vs -0.00

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.19

arrow
arrow

+62%

7.6M  vs 4.7M

Q2.20

arrow
arrow

-22%

13K  vs 16.7K

Q4.20

arrow
arrow

-9%

6.9M  vs 7.6M

Q2.21

arrow
arrow

-101%

-188.00  vs 13K

Q4.21

arrow
arrow

-100%

NA  vs 6.9M

Q2.22

arrow
arrow

+1465438%

2.8M  vs -188

Q4.22

arrow
arrow

NA

388K  vs NA

Q2.23

arrow
arrow

-81%

527K  vs 2.8M

Q4.23

arrow
arrow

-3%

377.9K  vs 388K

Q2.24

arrow
arrow

+221%

1.7M  vs 527K

Return on EquityShape

status-upQoQ

Q4.20

arrow
arrow

+3%

0.03
vs -0.41

Q2.21

arrow
arrow

-19%

-0.19
vs 0.03

Q4.21

arrow
arrow

-45%

-0.45
vs -0.19

Q2.22

arrow
arrow

-82%

-0.82
vs -0.45

Q4.22

arrow
arrow

-27%

-0.27
vs -0.82

Q2.23

arrow
arrow

-20%

-0.20
vs -0.27

Q4.23

arrow
arrow

-12%

-0.12
vs -0.20

Q2.24

arrow
arrow

-8%

-0.08
vs -0.12

Institutionnal OwnershipShape

status-upQoQ

Q3.21

arrow
arrow

1

1
vs NA

NA

Q4.21

arrow
arrow

1

1
vs 1

NA

Q1.22

arrow
arrow

1

1
vs 1

NA

Q2.22

arrow
arrow

1

1
vs 1

NA

Earnings Growth

Latest News